Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest Profit Margin

Below are the top biotechnology stocks on the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Osiris Therapeutics, Inc. OSIR is 94.20%. Osiris Therapeutics' ROA for the same period is 50.30%. The trailing-twelve-month profit margin at Enzon Pharmaceuticals Inc. ENZN is 88.20%. Enzon Pharmaceuticals' EPS for the same period is $0.64. The trailing-twelve-month profit margin at Gilead Sciences Inc. GILD is 72.30%. Gilead Sciences' PEG ratio is 0.52. The trailing-twelve-month profit margin at Enanta Pharmaceuticals, Inc. ENTA is 65.90%. Enanta Pharmaceuticals' revenue for the same period is $124.30 million.